(NBC News) — After enduring sharp criticism for dramatically raising its prices, drug maker Mylan has announced it’s launching its own generic version of the Epipen.
The generic will be listed at $300, half the cost of the brand-name Epipen.
Mylan’s CEO released a statement reading in part that the generic will offer a “long-term solution to further reduce costs and ease the burden and complexity of the process on the patient.”
Some pharmacists are wary, saying they’ll believe it when actually see the price fall.
“I’m glad they’re potentially lowering the price, but even at $300 dollars it’s still very expensive,” says Cleveland Clinic chief pharmacy officer Dr. Scott Knoer.
Mylan’s generic auto-injector will be identical to the brand name product, and pharmacists will be able to swap in the generic if doctors write a prescription for Epipen.
Read more: http://nbcnews.to/2c4R9ZF